carvacrol has been researched along with Lung Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, A; Kar, P; Roy, A; Saleh-E-In, MM; Sharma, NR | 1 |
| Jung, CY; Kim, SY; Lee, C | 1 |
| Bahuguna, A; Bajpai, VK; Kang, SC; Khan, I; Kumar, P | 1 |
| Bajpai, VK; Bhardwaj, M; Huh, YS; Kang, SC; Khan, I; Lee, H; Oh, MH; Shukla, S | 1 |
4 other study(ies) available for carvacrol and Lung Neoplasms
| Article | Year |
|---|---|
Synthesis of Carvacrol Derivatives as Potential New Anticancer Agent against Lung Cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Copper; Cymenes; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Schiff Bases | 2022 |
Carvacrol Targets AXL to Inhibit Cell Proliferation and Migration in Non-small Cell Lung Cancer Cells.
Topics: Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cymenes; Humans; Lung Neoplasms; Monoterpenes; Promoter Regions, Genetic; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases | 2018 |
In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Survival; Cymenes; Emulsions; Gene Expression Regulation; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mitochondria; Monoterpenes; Reactive Oxygen Species | 2018 |
Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model.
Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cell Proliferation; Cyclooxygenase 2; Cymenes; Down-Regulation; Drug Carriers; Drug Screening Assays, Antitumor; Emulsions; Humans; Lung Neoplasms; Mice; Nanoparticles; Neoplasms, Experimental; Neovascularization, Pathologic; Particle Size; Platelet Endothelial Cell Adhesion Molecule-1; Surface Properties; Tumor Cells, Cultured; Vascular Endothelial Growth Factors | 2019 |